29.03.2021
Praful Chakkarwar – Country Manager, Novo Nordisk Pharma Singapore
Novo Nordisk Singapore's Praful Chakkarwar explains how he leverages his experience in a range of geographies in his current role, how COVID-19 has helped facilitate the affiliate's digital transformation, the burden of diabetes and obesity in Singapore, and his experience in bringing innovative new treatments in these fields onto the Singaporean market.
The way health services are rendered to patients is evolving well, but patient-doctor interactions and relationships still tend to be quite traditional. The last year changed this paradigm dramatically
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
